Elevated ANGPTL8 (Angiopoietin‐Like Protein 8) Levels as a Novel Predictor of Atherosclerosis in Type 2 Diabetes: Beyond Lipid Metabolism
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.044806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Huimin Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism The Affiliated Hospital of Qinghai University Xining China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Angiopoietin-like Proteins, Peptide Hormones, Lipid Metabolism. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
ANGPTL8 (angiopoietin‐like protein 8) regulates lipid metabolism, but its role in atherosclerosis among patients with type 2 diabetes, particularly through lipid‐independent mechanisms, remains unclear.
Methods
This matched case–control study included 202 patients with type 2 diabetes (101 with atherosclerosis, and 101 without) matched for age, body mass index, and sex. Atherosclerosis was assessed via carotid intima‐media thickness and plaque scores. Circulating ANGPTL8 levels were measured by ELISA. Associations were evaluated using multivariate logistic regression, restricted cubic splines, and mediation analyses.
Results
Patients with atherosclerosis had significantly higher circulating ANGPTL8 levels (529.96 [350.58–816.78] versus 470.62 [265.54–717.47] pg/mL; P =0.027). After adjusting for confounders, the highest ANGPTL8 quartile showed 3.71‐fold increased atherosclerosis risk (95% CI, 1.52–9.06; P =0.004) versus the lowest quartile. Each SD increase in ANGPTL8 was associated with 56% higher risk (odds ratio, 1.56 [95% CI, 1.18–2.05]). A significant linear dose–response relationship was observed ( P =0.036). Adding ANGPTL8 to traditional risk factors significantly improved discrimination (area under the curve, 0.62 [95% CI, 0.54–0.70]) and reclassification (net reclassification improvement, 0.40 [95% CI, 0.13–0.66]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism The Affiliated Hospital of Qinghai University Xining China.
- Department of Endocrinology and Metabolism Yibin Fifth People's Hospital Yibin China.
- Department of Traumatology and Orthopaedics The Affiliated Hospital of Qinghai University Xining China.
ORCID-Profile: Huimin Ye, Qiang Zhu, Huajie Zou
Zitieren
APA
Ye, H., Zhu, Q., Zong, Q., Luo, S., Ji, Z., Zhang, R., & Zou, H. (2026). Elevated ANGPTL8 (Angiopoietin‐Like Protein 8) Levels as a Novel Predictor of Atherosclerosis in Type 2 Diabetes: Beyond Lipid Metabolism. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044806
Vancouver
Ye H, Zhu Q, Zong Q, Luo S, Ji Z, Zhang R, et al. Elevated ANGPTL8 (Angiopoietin‐Like Protein 8) Levels as a Novel Predictor of Atherosclerosis in Type 2 Diabetes: Beyond Lipid Metabolism. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.044806
BibTeX
@article{Ye2026,
author = {Ye, Huimin and Zhu, Qiang and Zong, Qunchuan and Luo, Shanyu and Ji, Zonghong and Zhang, Ruixia and Zou, Huajie},
title = {Elevated ANGPTL8 (Angiopoietin‐Like Protein 8) Levels as a Novel Predictor of Atherosclerosis in Type 2 Diabetes: Beyond Lipid Metabolism},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.044806}
}
EUVIMED